Scolaris Content Display Scolaris Content Display

Oral non steroid anti‐inflammatories for children and adults with bronchiectasis

Contraer todo Desplegar todo

Abstract

disponible en

Background

Bronchiectasis is increasing recognised as a co‐morbidity in many respiratory illness. Anti inflammatory drugs may reduce the inflammatory cascade and thus reduce symptoms and slow long term pulmonary decline.

Objectives

To assess the role of non steroid anti inflammatory drugs (NSAIDs) on symptom control and natural history of the disease in children and adults with bronchiectasis.

Search methods

The Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Airways Group Specialised Register, MEDLINE and EMBASE databases were searched by the Cochrane Airways Group up to December 2008.

Selection criteria

Only randomised controlled trials were considered. Patients with radiological or clinical evidence of bronchiectasis were included. Patients with Cystic Fibrosis were excluded.

Data collection and analysis

The titles, abstracts and citations were independently reviewed by two reviewers to assess potential relevance for full review. No eligible trials were identified and thus no data were available for analysis.

Main results

No randomised or controlled trials were found.

Authors' conclusions

There are no randomised controlled that examined the effect of oral NSAIDs in patients with bronchiectasis. In view of some benefit shown by inhaled NSAIDs in bronchiectasis, RCTs are clearly needed to study the beneficial effect of oral NSAIDs in patients with bronchiectasis.

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Plain language summary

disponible en

Oral non steroid anti‐inflammatories for children and adults with bronchiectasis

Infection and inflammation play an important role in the symptomatology and disease progression in patients with bronchiectasis. Anti inflammatory drugs may reduce the inflammatory cascade and thus may be beneficial in people with bronchiectasis. Using the standard search module of the Cochrane Airways Group, no randomised controlled trials that assessed the use of oral non steroidal anti inflammatory drugs (NSAIDs) in bronchiectasis were found. Thus the routine use of NSAIDs in bronchiectasis cannot be recommended.